Campbell & Co Investment Adviser’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Buy |
142,708
+74,523
| +109% | +$1.04M | 0.13% | 249 |
|
|
2025
Q1 | $927K | Buy |
68,185
+30,500
| +81% | +$415K | 0.07% | 461 |
|
|
2024
Q4 | $768K | Buy |
+37,685
| New | +$768K | 0.06% | 501 |
|
|
2024
Q1 | – | Sell |
-65,105
| Closed | -$1.4M | – | 1159 |
|
|
2023
Q4 | $1.4M | Buy |
65,105
+47,847
| +277% | +$1.03M | 0.13% | 243 |
|
|
2023
Q3 | $356K | Buy |
+17,258
| New | +$356K | 0.04% | 655 |
|
|
2023
Q2 | – | Sell |
-9,005
| Closed | -$207K | – | 943 |
|
|
2023
Q1 | $207K | Buy |
+9,005
| New | +$207K | 0.04% | 726 |
|